Detailed Narrative
Q1 FY26 Financial Performance Overview
Aether Industries delivered a robust Q1 FY26, with total consolidated revenue growing 35% year-on-year to ₹2,587 million. EBITDA saw a significant increase of 94% YoY, reaching ₹781 million, leading to an expanded EBITDA margin of 30% compared to 22% in Q1 FY25. Profit After Tax (PAT) also surged by 57% YoY to ₹470 million, with the PAT margin improving to 18% from 16% in the prior year.
Large-Scale Manufacturing (LSM) and Contract Manufacturing (CEM) Growth
The large-scale manufacturing (LSM) vertical demonstrated strong demand, growing 9% YoY and 8% QoQ, with the addition of six new clients. The company's business model mix saw 51% contribution from LSM, 37% from Contract/Exclusive Manufacturing (CEM), and 10% from Contract Research and Manufacturing Services (CRAMS). A significant portion of CEM growth was driven by Baker Hughes, contributing approximately ₹410 million in revenue this quarter, with supplies made to their Indian entity.
Strategic Expansions and Capacity Building
Aether is on track with its capex plans, targeting ₹350 crores for FY26, allocated across R&D, Site 3++, and Site 5. The new Site 3+, dedicated to the Milliken contract, is expected to commence production by Q4 FY26. Site 5 in Panoli is progressing smoothly, with the first two production blocks targeted for commissioning by the end of Q3 FY26. The company also plans to expand its R&D facilities with a ₹30-40 crore investment, increasing labs from 15 to 18 and fume hoods from 65 to 130.
New Client Engagements and Contract Wins
A significant milestone was the execution of a 10-year contract manufacturing agreement with Milliken Chemical & Textile India Company Private Limited, a wholly-owned subsidiary of USA-headquartered Milliken & Company. Aether will be the sole contract manufacturing partner for a key strategic product, dedicating its new Site 3+ for this purpose. Management noted that this new product for Milliken will be manufactured for the first time globally by Aether.
Sectoral Mix Evolution and Export Strategy
The sectoral split for Q1 FY26 showed pharma and agro combined contributing 46%, while oil and gas contributed 19% and material science 17%. This shift aligns with the company's expectation for increased contributions from oil & gas and material science. Exports accounted for 33% of total revenues, with domestic sales at 66%, largely influenced by supplies to Baker Hughes' Indian entity. Key export geographies include Europe (10-11%), China (4-5%), Japan (3-4%), and the US (5-6%).
Working Capital Management and Debt Profile
Aether successfully reduced its working capital cycle to 190 days from 195 days as of March 31, 2025, with inventory days decreasing to 165 from 175. The company aims to further reduce the working capital cycle to 165-170 days by the end of FY26 and to 150 days in the next 2-3 years. Management clarified that the company primarily utilizes short-term working capital debt and has no long-term debt, with internal accruals expected to fund future needs.